Growth Drivers
Growing Demand for Drugs– On account of the increasing prevalence of chronic disorders across the globe has increased the demand for medicines for treatment. Further, the growing use of HTS for the drug development process is estimated to drive market growth. The number of drug users worldwide is expected to increase by over 10% by 2030.
Rising Geriatric Population – Owing to a weak immune system elderly population is more prone to various diseases such as dementia, high blood pressure, and diabetes, which is estimated to drive market growth. As of 2021, the elderly population in India is predicted to increase by over 9%.
Increasing Health Spending – Increased government programs and investments in medication research, are anticipated to drive the market growth According to the most recent expenditure data, in 2020, health spending in the US rose by over 9%.
Growing Pharmaceutical and Biotechnology Sectors – It is expected that the growing launch of new and advanced drugs, and strong investment in the biotech and pharmaceutical industries, are anticipated to drive market growth. According to estimates, the biotechnology sector in India has grown to a value of over USD 80 billion in 2022.
Challenges
Regionally, the global high-throughput screening (HTS) market is segmented into five major regions including North America, Europe, Asia Pacific, Latin America and Middle East & Africa region. The market in North America is expected to hold the highest market share by attaining the largest market revenue of USD 15722.9 Million by the end of 2030, up from a revenue of USD 7023.0 Million in the year 2020. The growth of the market in the region can primarily be attributed to the presence of a strong healthcare infrastructure, and for the presence of numerous healthcare companies who are working day in and out to develop advanced drugs and therapies to treat different diseases. According to the statistics by the World Bank, the current health expenditure, as a share of GDP, in North America, grew from 15.629% in the year 2013 to 16.415% in the year 2018. The market in the region is segmented by country into the United States and Canada, out of which, the market in the U.S. is expected to garner the highest market share throughout the forecast period and further grow with the highest CAGR of 8.6% during the forecast period.
On the other hand, the market in the Asia Pacific is expected to grow with the highest CAGR of 8.6% throughout the forecast period, on account of the rising demand for advanced medications, backed by the increasing prevalence of chronic diseases in the region. The Asia Pacific high-throughput screening market is segmented by country into China, India, Japan, South Korea, Vietnam, Singapore, Australia, and the Rest of Asia Pacific. Out of the market in these countries, the market in China is expected to garner the largest revenue of USD 2373.4 Million by the end of 2030, while the market in India is projected to grow with the highest CAGR of 9% during the forecast period.
The study further incorporates Y-O-Y Growth, market opportunities, demand & supply and forecast future opportunity in North America (United States, Canada, Mexico), South America, Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX [Belgium, Netherlands, Luxembourg], NORDIC [Norway, Denmark, Sweden, Finland], Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC [Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman], North Africa, South Africa, Rest of Middle East and Africa).
Base Year |
2024 |
Forecast Year |
2025-2037 |
CAGR |
10.7% |
Base Year Market Size (2024) |
USD 23.33 billion |
Forecast Year Market Size (2037) |
USD 88.41 billion |
Regional Scope |
|
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?